Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Jennifer Eng-Wong
Based on 9 articles published since 2009
(Why 9 articles?)
||||
Expertise Level
The expertise of Jennifer Eng-Wong ranks in the
  • Top 1.5%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 9 articles on the topic.
Graphical view (beta)
Aliases Eng-Wong, J   ·   Eng-Wong, Jennifer
Work Locations
Details
Most likely:    Genentech Inc.      
2018
  • Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autonoma de Barcelona, Centro de Investigación Biomédica en Red Cáncer, Barcelona, Spain. · Instituto do Cancer de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China. · Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. · Meyer Cancer Center at Weill Cornell Medical College, Medical Oncology/Solid Tumor Program, New York, NY, USA. · Product Development Oncology, Genentech Inc, South San Francisco, CA, USA. · Biostatistics, Biometrics, Roche Holding Ltd, Shanghai, China. · Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: · Pubmed 30217672
  • Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, USA. · Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif. · Clinical Research Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Northern Centre for Cancer Care, Newcastle upon Tyne, UK. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Medical Oncology, Instituto Português de Oncologia Francisco Gentil (IPOFG) Porto, Porto, Portugal. · Huntsman Cancer Institute, University of Utah, Salt Lake City, USA. · Biostatistics, Product Development, Roche Products Ltd, Welwyn Garden City, UK. · Clinical Science, Global Product Development, Roche Products Ltd, Welwyn Garden City, UK. · Oncology Biomarker Development (OBD), F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Product Development - Oncology, Genentech, Inc., South San Francisco. · Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29253081
  • National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. Electronic address: · British Columbia Cancer Agency - Vancouver Centre, University of British Columbia, Vancouver, Canada. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · Regional Cancer and Blood Services, Auckland City Hospital, Auckland, New Zealand. · Cancer Institute "Ion Chiricuta", Cluj-Napoca, Romania. · Clinical Science, Global Product Development, Roche Products Limited, Welwyn Garden City, UK. · Product Development - Oncology, Genentech, Inc., South San Francisco, CA, USA. · PDBB - Biostatistics, Roche Products Limited, Welwyn Garden City, UK. · Ramón y Cajal University Hospital, Madrid and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29223479
2017
  • Ander Urruticoechea, Onkologikoa Foundation, San Sebastián · Ander Urruticoechea, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, GEICAM · Montserrat Muñoz, Translational Genomics and Targeted Therapeutics in Solid Tumors and Hospital Clínic, Barcelona, GEICAM · Antonio Carlos Sánchez Ruiz, Hospital Universitario Puerta de Hierro, Madrid, Spain · Mohammed Rizwanullah, Beatson West of Scotland Cancer Centre, Glasgow · Hannah Douthwaite and Sarah Heeson, Roche, Welwyn Garden City, United Kingdom · Seock-Ah Im, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea · István Láng, National Institute of Oncology, Budapest, Hungary · Gianluca Tomasello, ASST di Cremona - Ospedale di Cremona, Cremona, Italy · Tanja Badovinac Crnjevic, F Hoffmann-La Roche, Basel, Switzerland · and Jennifer Eng-Wong, Genentech, South San Francisco, CA. · Pubmed 28437161
  • Oncologia Medica, Ospedale San Raffaele, Milan, Italy. · Genentech, Inc., Basel, Switzerland. · Oncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Samsung Medical Center, Seoul, Korea. · Postgraduate Medical Education Center, Warsaw, Poland. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, Republic of China. · Taipei-Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, Republic of China. · Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · Institute of Cancer Research, London, UK. · Roche Products Limited, Welwyn, UK. · Genentech, Inc., South San Francisco, CA, USA. · Fondazione Michelangelo, Milan, Italy. · Oncologia Medica, Ospedale San Raffaele, Milan, Italy. · Pubmed 28183321
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
Probable:    Georgetown University   Contact    
2016
  • Department of Medicine, Medstar Georgetown University Hospital, Washington, DC. · Biostatistics and Data Management Section, NCI, NIH, Bethesda, Maryland. · Department of Radiology, Walter Reed National Military Medical Center, Bethesda, Maryland. · Department of Medicine, Medstar Georgetown University Hospital, Washington, DC. · Department of Nuclear Medicine, NIH, Bethesda, Maryland. · Division of Neuroradiology and Breast Imaging, Department of Radiology, Medstar Georgetown University Hospital, Washington, DC. · Department of Laboratory Medicine, Medstar Georgetown University Hospital, Washington DC. · Division of Cancer Prevention, NCI, Rockville, Maryland. · Division of Oncology, University of Washington, Seattle, Washington. · Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC. · Pubmed 26758879
Possible:    National Institutes of Health      
2014
  • Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Rm, 7-E108, Bethesda 20892-9774, MD, USA. · Pubmed 25159706
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Jennifer Eng-Wong in 2009-2019 about Breast Neoplasms:

  • Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study. 2018
  • Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study. 2018
  • Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer. 2018
  • Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy. 2017
  • Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer. 2017
  • Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study. 2017
  • Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety. 2016
  • Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study. 2014
  • Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. 2012
Show List of Full Article Records
Google Searches

Learn more about Jennifer Eng-Wong using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Genentech Inc.
Georgetown University
National Institutes of Health
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Genentech Inc.
2018
  • Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autonoma de Barcelona, Centro de Investigación Biomédica en Red Cáncer, Barcelona, Spain. · Instituto do Cancer de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China. · Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. · Meyer Cancer Center at Weill Cornell Medical College, Medical Oncology/Solid Tumor Program, New York, NY, USA. · Product Development Oncology, Genentech Inc, South San Francisco, CA, USA. · Biostatistics, Biometrics, Roche Holding Ltd, Shanghai, China. · Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: · Pubmed 30217672
  • Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, USA. · Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif. · Clinical Research Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Northern Centre for Cancer Care, Newcastle upon Tyne, UK. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Medical Oncology, Instituto Português de Oncologia Francisco Gentil (IPOFG) Porto, Porto, Portugal. · Huntsman Cancer Institute, University of Utah, Salt Lake City, USA. · Biostatistics, Product Development, Roche Products Ltd, Welwyn Garden City, UK. · Clinical Science, Global Product Development, Roche Products Ltd, Welwyn Garden City, UK. · Oncology Biomarker Development (OBD), F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Product Development - Oncology, Genentech, Inc., South San Francisco. · Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29253081
  • National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. Electronic address: · British Columbia Cancer Agency - Vancouver Centre, University of British Columbia, Vancouver, Canada. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · Regional Cancer and Blood Services, Auckland City Hospital, Auckland, New Zealand. · Cancer Institute "Ion Chiricuta", Cluj-Napoca, Romania. · Clinical Science, Global Product Development, Roche Products Limited, Welwyn Garden City, UK. · Product Development - Oncology, Genentech, Inc., South San Francisco, CA, USA. · PDBB - Biostatistics, Roche Products Limited, Welwyn Garden City, UK. · Ramón y Cajal University Hospital, Madrid and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29223479
2017
  • Ander Urruticoechea, Onkologikoa Foundation, San Sebastián · Ander Urruticoechea, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, GEICAM · Montserrat Muñoz, Translational Genomics and Targeted Therapeutics in Solid Tumors and Hospital Clínic, Barcelona, GEICAM · Antonio Carlos Sánchez Ruiz, Hospital Universitario Puerta de Hierro, Madrid, Spain · Mohammed Rizwanullah, Beatson West of Scotland Cancer Centre, Glasgow · Hannah Douthwaite and Sarah Heeson, Roche, Welwyn Garden City, United Kingdom · Seock-Ah Im, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea · István Láng, National Institute of Oncology, Budapest, Hungary · Gianluca Tomasello, ASST di Cremona - Ospedale di Cremona, Cremona, Italy · Tanja Badovinac Crnjevic, F Hoffmann-La Roche, Basel, Switzerland · and Jennifer Eng-Wong, Genentech, South San Francisco, CA. · Pubmed 28437161
  • Oncologia Medica, Ospedale San Raffaele, Milan, Italy. · Genentech, Inc., Basel, Switzerland. · Oncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Samsung Medical Center, Seoul, Korea. · Postgraduate Medical Education Center, Warsaw, Poland. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, Republic of China. · Taipei-Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, Republic of China. · Centre for Molecular Pathology, Royal Marsden Hospital, London, UK. · Institute of Cancer Research, London, UK. · Roche Products Limited, Welwyn, UK. · Genentech, Inc., South San Francisco, CA, USA. · Fondazione Michelangelo, Milan, Italy. · Oncologia Medica, Ospedale San Raffaele, Milan, Italy. · Pubmed 28183321
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
Georgetown University
2016
  • Department of Medicine, Medstar Georgetown University Hospital, Washington, DC. · Biostatistics and Data Management Section, NCI, NIH, Bethesda, Maryland. · Department of Radiology, Walter Reed National Military Medical Center, Bethesda, Maryland. · Department of Medicine, Medstar Georgetown University Hospital, Washington, DC. · Department of Nuclear Medicine, NIH, Bethesda, Maryland. · Division of Neuroradiology and Breast Imaging, Department of Radiology, Medstar Georgetown University Hospital, Washington, DC. · Department of Laboratory Medicine, Medstar Georgetown University Hospital, Washington DC. · Division of Cancer Prevention, NCI, Rockville, Maryland. · Division of Oncology, University of Washington, Seattle, Washington. · Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC. · Pubmed 26758879
National Institutes of Health
2014
  • Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Rm, 7-E108, Bethesda 20892-9774, MD, USA. · Pubmed 25159706
George Washington University
2012
  • Department of Epidemiology and Biostatistics, The George Washington University School of Public Health and Health Services, 2100-W Pennsylvania Avenue, NW, 8th Floor, Washington, DC 20037, USA. · Pubmed 23045540
Yearly article counts 03310101000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.